A double-blind, placebo controlled, parallel group, multicenter study to assess the time to onset, safety, and toleration of differing doses and combinations of immediate release and modified release formulations of UK369,003 in adult male subject with erectile dysfunction.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2006
At a glance
- Drugs Gisadenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 30 Aug 2006 Status change
- 29 Oct 2005 New trial record.